Table 5.
Protein expression levels of IKCa2.3, IKCa3.1, AKT1, and P300 in each group. After the ANOVA for each group (p < 0.05), the variance for uneven group was tested using the Welch test, (p < 0.05), which means that there were statistical differences in many groups. Data are expressed as the mean ± SEM.
| Group | Control (n = 15) |
MR (n = 15) |
MS (n = 15) |
MR+AF (n = 15) |
MS+AF (n = 15) |
MS+AF+ Thrombus (n = 15) |
F | p Value |
|---|---|---|---|---|---|---|---|---|
| IKCa2.3 | 0.23 ± 0.14 | 0.55 ± 0.19 | 0.73 ± 0.44 * | 0.71 ± 0.34 | 1.47 ± 0.75 *,#,Δ,a | 0.84 ± 0.21 *,# | 10.620 | 0.042 |
| IKCa3.1 | 0.27 ± 0.21 | 0.47 ± 0.22 | 0.37 ± 0.29 | 0.58 ± 0.21 | 1.33 ± 0.62 *,#,Δ,a | 0.96 ± 0.51 *,#,Δ | 15.229 | <0.001 |
| P300 | 0.31 ± 0.11 | 0.47 ± 0.34 | 0.81 ± 0.37 | 0.37 ± 0.24 | 0.87 ± 0.44 | 0.84 ± 0.76 | 2.623 | 1.334 |
| AKT1 | 0.32 ± 0.21 | 0.45 ± 0.26 | 0.73 ± 0.37 * | 0.58 ± 0.36 | 1.43 ± 0.37 *,#,Δ,a | 1.18 ± 0.51 *,#,Δ,a,b | 11.711 | 0.001 |
* significant differences from the control group, p < 0.05; # significant differences from the MR group, p < 0.05; Δ significant differences from the MS group, p < 0.05; a significant differences from the MR+AF group, p < 0.05; b significant differences from the MS+AF group, p < 0.05.